STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
TPTX TURNING POINT THERAPEUTICS INCORPORATED StockScouter® Report
1
StockScouter® Score
TURNING POINT THERAPEUTICS INCORPORATED, a mid cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Moving average analysis for TPTX suggests strong price movement over the medium term. Positive
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
C
C
F
D